Search

OraSure Technologies Inc

Aperta

SettoreSettore sanitario

3.87 2.65

Panoramica

Variazione del prezzo dell'azione

24h

Corrente

Minimo

3.69

Massimo

3.85

Metriche Chiave

By Trading Economics

Entrata

29M

6.2M

Vendite

2.7M

31M

EPS

-0.23

Margine di Profitto

20.396

Dipendenti

500

EBITDA

25M

4.3M

Dividendi

By Acuity

Utili prossimi

4 nov 2026

Statistiche di mercato

By TradingEconomics

Capitalizzazione di Mercato

-24M

263M

Apertura precedente

1.22

Chiusura precedente

3.87

Notizie sul Sentiment di mercato

By Acuity

9%

91%

12 / 340 Classifica in Healthcare

OraSure Technologies Inc Grafico

Le prestazioni passate non sono un indicatore affidabile dei risultati futuri.

Notizie correlate

20 ago 2026, 19:26 UTC

OraSure Technologies is trading roughly flat as no specific news emerged during Thursday's session. The asset remains significantly below its 20-day moving average.

18 ago 2026, 20:06 UTC

OraSure Technologies Inc shares are lower today, continuing a downward trend since Monday. The stock is trading significantly below its 20-day moving average.

17 ago 2026, 19:36 UTC

OraSure Technologies Inc is declining today, influenced by a drop in the Health Care Supplies sub-sector. The stock remains below its 20-day moving average.

14 ago 2026, 19:51 UTC

OraSure Technologies Inc. shares are lower amid broader market declines following a surprise drop in U.S. retail sales for July.

13 ago 2026, 20:02 UTC

OraSure Technologies Inc is higher during Thursday's session, recovering from three consecutive declines. No specific company news has been identified to explain the movement.

12 ago 2026, 20:01 UTC

OraSure Technologies Inc shares are lower today, continuing a decline since Tuesday's close. No specific news was identified to explain the drop.

11 ago 2026, 19:46 UTC

OraSure Technologies Inc shares are lower today, continuing a downward trend since Monday's close amid broader market influences from recent economic data.

10 ago 2026, 19:56 UTC

News

OraSure Technologies reported second-quarter revenue of $30.6 million, driven by public-health diagnostics. Shares are lower despite positive developments and improved gross margins.

7 ago 2026, 19:36 UTC

OraSure Technologies Inc is rising, supported by broader market momentum amid expectations for a pause in interest rate hikes following a weaker jobs report.

6 ago 2026, 20:03 UTC

News

OraSure Technologies reported Q2 earnings above guidance but announced a delay in FDA clearance for its InteliQuick CT/NG product, contributing to a decline in shares.

5 ago 2026, 20:06 UTC

OraSure Technologies Inc. shares are lower today, pulling back from earlier gains. The stock remains above its 20-day moving average despite the decline.

4 ago 2026, 20:02 UTC

OraSure Technologies Inc is rising amid broader market gains, supported by declining crude oil prices and positive comments on potential peace talks with Iran.

3 ago 2026, 20:07 UTC

OraSure Technologies Inc. is gaining today, rebounding from earlier session lows. The broader market also shows positive momentum, with the S&P 500 rising.

31 lug 2026, 20:02 UTC

OraSure Technologies Inc. is trading higher amid overall market gains, despite no specific company news. Rising Treasury yields and crude oil prices contribute to inflation concerns.

30 lug 2026, 18:46 UTC

OraSure Technologies Inc shares are higher today, though no specific news explains the movement. The stock remains near its one-month range low.

29 lug 2026, 17:02 UTC

OraSure Technologies Inc is declining during Wednesday's session, trading well below its 20-day moving average and near the lower end of its one-month range.

28 lug 2026, 19:26 UTC

OraSure Technologies Inc is trading higher today, reflecting a positive move since Monday. The stock remains below its 20-day moving average.

27 lug 2026, 17:02 UTC

News

OraSure Technologies Inc shares are lower as analyst sentiment shifts. Wall Street Zen upgraded the stock, while Weiss Ratings downgraded its outlook.

24 lug 2026, 20:02 UTC

OraSure Technologies Inc. shares are lower today, reflecting broader market trends, and remain below their 20-day moving average.

23 lug 2026, 20:03 UTC

OraSure Technologies Inc is rising sharply during Thursday's session, reflecting notable volatility and a strong upward trend since Wednesday's close.

22 lug 2026, 18:46 UTC

News

OraSure Technologies received FDA Emergency Use Authorization for its OraQuick Ebola 2.0 test. Shares are trading roughly flat since Tuesday's close.

21 lug 2026, 22:02 UTC

News

OraSure Technologies received FDA Emergency Use Authorization for its OraQuick Ebola 2.0 Rapid Antigen Test. Shares are higher in after-market hours amid increased production plans.

Confronto tra pari

Modifica del prezzo

OraSure Technologies Inc Previsione

Consenso sulla valutazione

By TipRanks

0 ratings

0

Acquista

0

Mantieni

0

Vendi

Sentiment

By Acuity

12 / 340 Classifica in Settore sanitario

Notizie sul Sentiment di mercato

Prove rialziste molto forti

Volatilità

Sotto la media

Volume delle notizie (RCV)

Sopra la media

Notizie finanziarie

Spese di vendita e di amministrazione

Spese operative

Utile prima delle imposte

Vendite

Costo delle vendite

Utile lordo sulle vendite

Interessi passivi sul debito

EBITDA

Utile operativo

$

Chi Siamo OraSure Technologies Inc

OraSure Technologies, Inc., together with its subsidiaries, provides point-of-care and home diagnostic tests, specimen collection devices, and microbiome laboratory and analytical services in the United States, Europe, and internationally. The company's products include InteliSwab COVID-19 rapid test, InteliSwab COVID-19 rapid test pro, InteliSwab COVID-19 rapid test rx, OraQuick Rapid HIV test, OraQuick In-Home HIV test, OraQuick HIV self-test, OraQuick HCV rapid antibody test, OraQuick Ebola rapid antigen test, OraSure oral fluid collection device used in conjunction with screening and confirmatory tests for HIV-1 antibodies; Intercept drug testing systems; immunoassay tests and reagents; and Q.E.D. saliva alcohol test. It also offers genomic products under the Oragene and ORAcollect brands for collecting genetic material from human saliva; Colli-Pee collection devices for the volumetric collection of void urine samples; and microbiome laboratory testing and analytical services. In addition, the company provides microbiome products, such as OMNIgene GUT for self-collecting microbial DNA from feces or stool samples for gut microbiome profiling; OMNIgene GUT DNA and RNA collection devices; and OMNIgene GUT Dx collection device for collection of human fecal samples and the stabilization of DNA from the bacterial community. Additionally, it provides other diagnostic products, such as immunoassays and other in vitro diagnostic tests. The company markets its products to clinical laboratories, hospitals, clinics, community-based organizations and other public health organizations, distributors, government agencies, physicians' offices, commercial and industrial entities, disease risk management, diagnostics, pharmaceutical, biotech, nutrition, companion animal, and environmental markets. OraSure Technologies, Inc. was incorporated in 2000 and is based in Bethlehem, Pennsylvania.
help-icon Live chat